We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phoenix Group Holdings Plc | LSE:PHNX | London | Ordinary Share | GB00BGXQNP29 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.20 | 0.25% | 486.40 | 486.00 | 486.40 | 487.80 | 484.20 | 485.00 | 372,523 | 10:02:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Life Insurance | 22.81B | -116M | -0.1159 | -42.02 | 4.88B |
TIDMSLA TIDMPHNX
RNS Number : 0388N
Standard Life Aberdeen plc
03 May 2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
Standard Life Aberdeen plc
Phoenix Group Holdings
Update on proposed transaction
Standard Life Aberdeen plc ("Standard Life Aberdeen") and Phoenix Group Holdings ("Phoenix") are providing an update regarding the proposed sale of Standard Life Aberdeen's UK and European insurance business ("Standard Life Assurance") to Phoenix (the "proposed transaction"). As previously announced, the proposed transaction is expected to complete in the third quarter of 2018.
Phoenix and Standard Life Aberdeen are actively progressing with the separation and integration planning for the proposed transaction. As part of this process, Standard Life Aberdeen continues to engage with its UK regulators in relation to the future prudential supervision of the group. Standard Life Aberdeen is also considering the potential for a substantial return of capital to shareholders following completion.
Phoenix has made good progress with the financing for the proposed transaction, having issued its inaugural Restricted Tier I bond on 26 April 2018, and continues to engage with its regulators.
It is expected that the general meetings for each of Standard Life Aberdeen and Phoenix shareholders to approve the transaction will be held contemporaneously. It is expected that the parties' respective circulars and the Phoenix prospectus will be published shortly after 29 May 2018, which is the date of Standard Life Aberdeen's annual general meeting. The general meetings of Standard Life Aberdeen and Phoenix to approve the proposed transaction will take place as soon as practicable thereafter, in line with conventional notice periods.
3 May 2018
Contacts:
Media Enquiries
Katy Hetherington, PR Manager, +44 (0) 131 245 2283*
Standard Life Aberdeen +44 (0) 7841 344 374
Investor Enquiries
Jakub Rosochowski, Investor Relations Director, +44 (0) 131 245 8028*
Standard Life Aberdeen +44 (0) 7515 298 608
Neil Longair, Investor Relations Manager, +44 (0) 131 245 6466* Standard Life Aberdeen +44 (0) 7711 357 595
* Calls may be monitored and/or recorded to protect both you and us and help with our training. Call charges will vary.
Standard Life Aberdeen plc LEI: OTMBS544NMO7GLCE7H90
Classification: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCAJMMTMBJMBPP
(END) Dow Jones Newswires
May 03, 2018 07:30 ET (11:30 GMT)
1 Year Phoenix Chart |
1 Month Phoenix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions